Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000016

Director sold 10,722 shares at $21.64 ($232,024)

  • Director acquired 23,900 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-20 Exercise or conversion : show line 1 in the form 10b5-1 +23,900 139,975 D
2024-01-24 Sale : show line 2 in the form 10b5-1 −10,722 $21.64 $232,024 129,253 D
Open-market sales · 10,722 sh · avg $21.64 · $232,024

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-20 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −23,900 0 D
Loading xslF345X05/wk-form4_1706131320.xml…